UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes

Bone marrow transplantation (Basingstoke), 2015-09, Vol.50 (9), p.1168-1172

2015

Volltextzugriff (PDF)

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.819-824

2013

Volltextzugriff (PDF)

Cord blood transplantation in aplastic anemia

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.201-202

2013

Volltextzugriff (PDF)

The first steps towards a diverse and inclusive EBMT: a position paper

Bone marrow transplantation (Basingstoke), 2022-03, Vol.57 (3), p.343-346

2022

Volltextzugriff (PDF)

Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

Bone marrow transplantation (Basingstoke), 2017-05, Vol.52 (5), p.689-696

2017

Volltextzugriff (PDF)

Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS

Bone marrow transplantation (Basingstoke), 2013-10, Vol.48 (10), p.1296-1301

2013

Volltextzugriff (PDF)

Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy

Bone marrow transplantation (Basingstoke), 2015-12, Vol.50 (12), p.1586-1588

2015

Volltextzugriff (PDF)

Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.849-853

2013

Volltextzugriff (PDF)

In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?

Bone marrow transplantation (Basingstoke), 2015-11, Vol.50 (11), p.1411-1415

2015

Volltextzugriff (PDF)

Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2014-08, Vol.49 (8), p.1089-1092

2014

Volltextzugriff (PDF)

Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Bone marrow transplantation (Basingstoke), 2015-02, Vol.50 (2), p.253-258

2015

Volltextzugriff (PDF)

Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2016-02, Vol.51 (2), p.313-315

2016

Volltextzugriff (PDF)

Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.928-932

2016

Volltextzugriff (PDF)

Effectiveness of brentuximab vedotin before and after allogeneic stem‐cell transplantation in the management of transformed mycosis fungoides

British journal of dermatology (1951), 2020-06, Vol.182 (6), p.1503-1504

2020

Volltextzugriff (PDF)

Hepatic GVHD leading to cirrhosis after allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2012-11, Vol.47 (11), p.1484-1485

2012

Volltextzugriff (PDF)

Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis

Bone marrow transplantation (Basingstoke), 2011-04, Vol.46 (4), p.557-561

2011

Volltextzugriff (PDF)

Efficacy and safety of brentuximab vedotin plus bendamustine in advanced‐stage primary cutaneous T‐cell lymphomas

British journal of dermatology (1951), 2019-12, Vol.181 (6), p.1315-1317

2019

Volltextzugriff (PDF)

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study

Bone marrow transplantation (Basingstoke), 2024-02, Vol.59 (2), p.232-238

2024

Volltextzugriff (PDF)

FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study

Bone marrow transplantation (Basingstoke), 2021-01, Vol.56 (1), p.285-288

2021

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Leukemia, 2021, Vol.35 (1), p.225-228

2021

Volltextzugriff (PDF)

Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft‐versus‐host disease

British journal of dermatology (1951), 2017-11, Vol.177 (5), p.e206-e208

2017

Volltextzugriff (PDF)

Complete remission of sclerodermatous cutaneous graft‐versus‐host disease after low‐dose interleukine‐2 treatment

Journal of the European Academy of Dermatology and Venereology, 2020-12, Vol.34 (12), p.e791-e793

2020

Volltextzugriff (PDF)

Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Bone marrow transplantation (Basingstoke), 2017-05, Vol.52 (5), p.678-682

2017

Volltextzugriff (PDF)

Double cord blood transplantation in patients with high risk bone marrow failure syndromes

British journal of haematology, 2008-11, Vol.143 (3), p.404-408

2008

Volltextzugriff (PDF)

Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)

Bone marrow transplantation (Basingstoke), 2014-06, Vol.49 (6), p.756-760

2014

Volltextzugriff (PDF)

1 – 25 von 217

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bone Marrow Transplantation
(45)
Haematologica
(24)
Blood
(20)
Hemasphere
(13)
Annales De Dermatologie Et De Vénéréologie
(12)
British Journal Of Dermatology
(6)
La Revue De Medecine Interne
(6)
Leukemia
(5)
Pathologie Biologie
(5)
Transplantation
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis

Cord blood transplantation in aplastic anemia

The first steps towards a diverse and inclusive EBMT: a position paper

Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS

Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy

Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia

In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?

Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT

Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation

Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Effectiveness of brentuximab vedotin before and after allogeneic stem‐cell transplantation in the management of transformed mycosis fungoides

Hepatic GVHD leading to cirrhosis after allogeneic hematopoietic SCT

Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis

Efficacy and safety of brentuximab vedotin plus bendamustine in advanced‐stage primary cutaneous T‐cell lymphomas

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study

FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft‐versus‐host disease

Complete remission of sclerodermatous cutaneous graft‐versus‐host disease after low‐dose interleukine‐2 treatment

Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Double cord blood transplantation in patients with high risk bone marrow failure syndromes

Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)

Suchergebnisse filtern